$13.00
-0.47-3.49%
At close: Dec 16, 4:00 PM EST
$13.00
N/A
After Hours: 4:04 PM EST
Comments
Loading...
Integra Lifesciences Stock Guidance | NASDAQ:IART | Benzinga
Integra Lifesciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/30/2025 | IART | Integra Lifesciences | Q4 | 2025 | $0.79 | $0.84 | $0.72 | $420.00M | $440.00M | $439.64M | Get Alert |
| 10/30/2025 | IART | Integra Lifesciences | FY | 2025 | $2.19 | $2.24 | $2.21 | $1.62B | $1.64B | $1.67B | Get Alert |
| 07/31/2025 | IART | Integra Lifesciences | FY | 2025 | $2.19 | $2.29 | $2.24 | $1.66B | $1.68B | $1.67B | Get Alert |
| 07/31/2025 | IART | Integra Lifesciences | Q3 | 2025 | $0.40 | $0.45 | $0.58 | $410.00M | $420.00M | $418.90M | Get Alert |
| 05/05/2025 | IART | Integra Lifesciences | Q2 | 2025 | $0.40 | $0.45 | $0.57 | $390.00M | $400.00M | $417.04M | Get Alert |
| 05/05/2025 | IART | Integra Lifesciences | FY | 2025 | $2.19 | $2.29 | $2.46 | $1.65B | $1.72B | $1.68B | Get Alert |
| 02/25/2025 | IART | Integra Lifesciences | Q1 | 2025 | $0.40 | $0.45 | $0.56 | $375.00M | $385.00M | $411.71M | Get Alert |
| 02/25/2025 | IART | Integra Lifesciences | FY | 2025 | $2.41 | $2.51 | $2.51 | $1.65B | $1.72B | $1.71B | Get Alert |
| 11/04/2024 | IART | Integra Lifesciences | FY | 2024 | $2.41 | $2.49 | $2.45 | $1.61B | $1.62B | $1.61B | Get Alert |
| 11/04/2024 | IART | Integra Lifesciences | Q4 | 2024 | $0.81 | $0.89 | $0.87 | $441.00M | $451.00M | $448.47M | Get Alert |
| 07/29/2024 | IART | Integra Lifesciences | Q3 | 2024 | $0.36 | $0.44 | $0.85 | $372.00M | $382.00M | $432.11M | Get Alert |
| 07/29/2024 | IART | Integra Lifesciences | FY | 2024 | $2.41 | $2.57 | $3.04 | $1.61B | $1.63B | $1.68B | Get Alert |
| 05/06/2024 | IART | Integra Lifesciences | FY | 2024 | $3.01 | $3.11 | $3.19 | $1.67B | $1.69B | $1.62B | Get Alert |
| 05/06/2024 | IART | Integra Lifesciences | Q2 | 2024 | $0.60 | $0.65 | $0.75 | $411.00M | $416.00M | $395.80M | Get Alert |
| 02/28/2024 | IART | Integra Lifesciences | FY | 2024 | $3.15 | $3.25 | $3.44 | $1.60B | $1.62B | $1.62B | Get Alert |
| 02/28/2024 | IART | Integra Lifesciences | Q1 | 2024 | $0.53 | $0.57 | $0.74 | $360.00M | $365.00M | $380.89M | Get Alert |
| 10/25/2023 | IART | Integra Lifesciences | FY | 2023 | $3.10 | $3.14 | $3.14 | $1.54B | $1.55B | $1.55B | Get Alert |
| 10/25/2023 | IART | Integra Lifesciences | Q4 | 2023 | $0.89 | $0.93 | $0.78 | $397.00M | $403.00M | $387.12M | Get Alert |
| 07/26/2023 | IART | Integra Lifesciences | Q3 | 2023 | $0.76 | $0.80 | $0.97 | $386.00M | $390.00M | $411.86M | Get Alert |
| 07/26/2023 | IART | Integra Lifesciences | FY | 2023 | $3.10 | $3.18 | $3.12 | $1.55B | $1.56B | $1.56B | Get Alert |
| 05/23/2023 | IART | Integra Lifesciences | Q2 | 2023 | $0.55 | $0.59 | $0.77 | $372.00M | $376.00M | $398.13M | Get Alert |
| 04/26/2023 | IART | Integra Lifesciences | FY | 2023 | $3.43 | $3.51 | $3.48 | $1.60B | $1.62B | $1.61B | Get Alert |
| 04/26/2023 | IART | Integra Lifesciences | Q2 | 2023 | $0.75 | $0.79 | $0.85 | $396.00M | $400.00M | $404.78M | Get Alert |
| 02/22/2023 | IART | Integra Lifesciences | FY | 2023 | $3.43 | $3.51 | $3.52 | $1.60B | $1.62B | $1.62B | Get Alert |
| 02/22/2023 | IART | Integra Lifesciences | Q1 | 2023 | $0.72 | $0.76 | $0.79 | $370.00M | $376.00M | $381.72M | Get Alert |
| 01/25/2023 | IART | Integra Lifesciences | FY | 2022 | $3.34 | $3.38 | $3.30 | — | — | — | Get Alert |
| 01/25/2023 | IART | Integra Lifesciences | Q4 | 2022 | $0.92 | $0.96 | $0.89 | — | — | — | Get Alert |
| 01/10/2023 | IART | Integra Lifesciences | FY | 2022 | $3.33 | — | $3.30 | $1.56B | $1.56B | $1.56B | Get Alert |
| 01/10/2023 | IART | Integra Lifesciences | Q4 | 2022 | $0.91 | — | $0.89 | $397.00M | $398.00M | $397.50M | Get Alert |
| 10/26/2022 | IART | Integra Lifesciences | FY | 2022 | $3.29 | $3.33 | $3.15 | $1.55B | $1.56B | $1.56B | Get Alert |
| 10/26/2022 | IART | Integra Lifesciences | Q4 | 2022 | $0.87 | $0.91 | $0.88 | $391.00M | $403.00M | $403.50M | Get Alert |
| 08/24/2022 | IART | Integra Lifesciences | FY | 2022 | $3.12 | $3.20 | $3.24 | $1.55B | $1.57B | $1.57B | Get Alert |
| 08/24/2022 | IART | Integra Lifesciences | Q3 | 2022 | $0.69 | $0.73 | $0.80 | $374.00M | $382.00M | $387.79M | Get Alert |
| 07/27/2022 | IART | Integra Lifesciences | FY | 2022 | $3.21 | $3.29 | $3.31 | $1.56B | $1.57B | $1.59B | Get Alert |
| 07/27/2022 | IART | Integra Lifesciences | Q3 | 2022 | $0.78 | $0.82 | $0.84 | $383.00M | $391.00M | $398.66M | Get Alert |
| 04/27/2022 | IART | Integra Lifesciences | Q2 | 2022 | $0.78 | $0.82 | $0.80 | $392.00M | $400.00M | $394.32M | Get Alert |
| 04/27/2022 | IART | Integra Lifesciences | FY | 2022 | $3.27 | $3.35 | $3.31 | $1.58M | $1.60B | $1.59B | Get Alert |
| 02/23/2022 | IART | Integra Lifesciences | Q1 | 2022 | $0.67 | $0.71 | $0.73 | $357.00M | $365.00M | $378.50M | Get Alert |
| 02/23/2022 | IART | Integra Lifesciences | FY | 2022 | $3.27 | $3.35 | $3.42 | $1.58B | $1.60B | $1.63B | Get Alert |
| 01/11/2022 | IART | Integra Lifesciences | FY | 2021 | — | — | — | $1.54B | $1.54B | $1.54B | Get Alert |
| 01/11/2022 | IART | Integra Lifesciences | Q4 | 2021 | — | — | — | $404.00M | $406.00M | $403.94M | Get Alert |
FAQ
Q
What is the most recent guidance for Integra Lifesciences (IART)?
A
The most recent guidance for Integra Lifesciences (IART) was reported on October 30, 2025 for Q4 2025. The company provided earnings per share guidance in the range of $0.79 to $0.84, compared to the estimated EPS of $0.72. Additionally, Integra Lifesciences forecasted revenue between $0.42B and $0.44B for the quarter.
Browse guidance and forecast on all stocks.
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved